We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Accrol Group Holdings Plc | LSE:ACRL | London | Ordinary Share | GB00BZ6VT592 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 38.20 | 38.00 | 38.40 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Convrt Paper,paperbd Pds,nec | 241.91M | -5.7M | -0.0179 | -21.34 | 121.81M |
TIDMACRL
RNS Number : 1775C
Accrol Group Holdings PLC
17 January 2018
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
17 January 2018
Accrol Group Holdings plc
(the "Company")
Update on Health and Safety Incident
Further to the Update on Health & Safety Incident announcement made by Accrol Group Holdings plc (AIM:ACRL) on 12 October 2017, the Company announces that, at the sentencing hearing today, Accrol Papers Limited (a directly owned subsidiary of the Company) was fined GBP120,000 (after discount) for a single health and safety regulatory offence.
The sentencing court commented that the fine had been reduced by one third in light of the guilty plea entered at the earliest opportunity and the Company's full co-operation with the HSE investigation. The Company has been given 12 months to pay the fine.
As previously reported, the Health & Safety Executive (HSE) had previously indicated to the Company that it was seeking a fine in the range of GBP550,000 to GBP2.9m for this incident.
Accrol takes the Health and Safety of its employees very seriously and the directors are pleased that this has been recognised in today's judgement.
For further information, please contact: Accrol Group Holdings plc Tel: +44 (0) 1254 278844 Gareth Jenkins, Chief Executive Officer Zeus Capital Limited (Nominated Adviser & Broker) Dan Bate / Andrew Jones Tel: +44 (0) 161 831 1512 Dominic King / John Goold Tel: +44 (0) 203 829 5000 Belvedere Communications Tel: +44 (0) 20 3567 Limited 0510 Cat Valentine cvalentine@belvederepr.com John West jwest@belvederepr.com Kim Van Beeck kvbeeck@belvederepr.com
Notes to Editors
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues as well as other tissue products to the UK's largest retailers.
Accrol operates from three sites:
-- a manufacturing, storage and distribution facility in Blackburn; -- a facial tissue plant, also in Blackburn; and -- a manufacturing, storage and distribution facility in Leyland.
In addition, the business has a 368,000 sq ft storage and distribution facility in Skelmersdale, Lancashire.
Accrol manufactures approximately 18 million units per week, supplying customers with both Accrol branded and "private label" products.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ARILLFFELVIDLIT
(END) Dow Jones Newswires
January 17, 2018 10:25 ET (15:25 GMT)
1 Year Accrol Chart |
1 Month Accrol Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions